Be The Match disclosed on Tuesday that C. Randal Mills, PhD will step down as its chief executive officer for personal reasons.
Until Dr Mills' successor is elected, Amy Ronneberg, the company's chief financial officer and chief of staff, will serve as the acting CEO.
In May 2017, Dr Mills was appointed to the company as its CEO, replacing the outgoing Jeffrey Chell, MD, who left in 2000.
Be The Match is a non-profit organisation that delivers cures to patients in need of a life-saving marrow or umbilical cord blood transplant. It also conducts research through the CIBMTR (Center for International Blood and Marrow Transplant Research) programme.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer